Black Diamond Therapeutics (BDTX) PT Raised to $16 at Wedbush
Tweet Send to a Friend
Wedbush analyst Robert Driscoll raised the price target on Black Diamond Therapeutics (NASDAQ: BDTX) to $16.00 (from $10.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
